GRETCHEN RUDESEAL-ARNOLD: Open Payments
NPI 1366222036 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 9 companies in 2025. Trend: 2023 $44 · 2024 $258 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: AIRSUPRA, Kerendia, REXULTI, LEQVIO, Evoke, Cologuard Collection Kit, XYOSTED, Tirosint.
Industry payments across AL — which companies pay providers there.
